Skip to main content
. 2021 Apr 9;22:14. doi: 10.1186/s12863-021-00968-1

Table 1.

Main characteristics of the studies of APOA included in the review

SNP First author Year Area Sample size Age (y) Source of control Genotyping method Cases Controls NOS HWE
Case Control Case Control TT/GG/CC CT/GA/CT CC/AA/TT TT/GG/CC CT/GA/CT CC/AA/TT χ2 P

APOA5–1131

T>C

Zhao DD [11] 2007 Beijing, China 172 80 NR NR HB PCR-RFLP 63 86 23 39 36 5 7 0.77 0.37
Niu ZB [12] 2016 Shanghai, China 156 262 NR NR PB MALDI-TOF 68 68 20 153 94 15 9 0.01 0.91
Huang M [13] 2008 Taiwan, China 76 240 59.57 ± 10.2 60.98 ± 13.58 PB PCR-RFLP 15 41 20 99 111 30 8 0.02 0.9
Long SY [14] 2013 Hunan, China 95 102 61 ± 12 62 ± 12 HB PCR-RFLP 46 36 13 50 45 7 7 0.54 0.46
Maria [15] 2014 Napoli, Italian 165 142 47.5 ± 12.2 43.9 ± 9.6 HB TaqMan 111 49 5 117 23 2 7 0.49 0.48
Cláudia [16] 2012 Minas Gerais, Brazil 108 107 48.4 ± 6.8 46.7 ± 6.6 PB PCR-RFLP 52 52 4 71 33 3 7 0.13 72
Brito [17] 2010 Belo Horizonte, Brazil 53 77 10.4 ± 2.7 11.2 ± 3.4 HB PCR-RFLP 34 14 5 62 13 2 6 1.52 0.22
ZK Liu [18] 2009 Hongkong, China 56 176 49.6 ± 12.3 50.1 ± 9.4 HB PCR 9 27 20 101 61 11 7 0.19 0.66
Peter H [19] 2008 Netherlands 254 240 NR NR HB PCR 142 72 7 172 22 1 6 0.11 0.75
Han Y [8] 2012

Hunan,

China

109 117 60.3 ± 12.1 62.9 ± 12.0 HB PCR-RFLP 52 43 14 59 50 8 7 0.36 0.55
APOA1-75 bp Huang G [20] 2011

Xinjiang,

China

275 252 47.7 ± 7.9 48.23 ± 7.6 HB PCR-RFLP 135 102 38 136 95 21 8 0.57 0.49
Feng DW [7] 2016

Xinjiang,

China

365 370 46.8 ± 15.9 45.21 ± 16.4 PB PCR 248 104 13 280 83 7 9 0.09 0.77
Feng DW [7] 2016

Xinjiang,

China

345 391 43.9 ± 14.3 41.5 ± 13.3 PB PCR 250 87 7 299 86 5 9 0.18 0.67
Chi YH [21] 2012 Xinjiang,China 200 200 58.5 ± 11.8 58.3 ± 11.5 PB PCR-RFLP 116 82 2 124 73 5 7 2.31 1.29
Bora K [2] 2017 Assam, India 100 100 43.1 ± 11.6 43.0 ± 11.6 PB PCR-RFLP 62 35 3 60 33 7 8 0.68 0.41
APOA1+83 bp Xie YJ [22] 2011

Xinjiang,

China

150 150 56.8 ± 10.8 58.1 ± 10.5 HB PCR-RFLP 126 24 0 130 20 0 7 0.77 0.38
Ou HJ [5] 2015

Xinjiang,

China

241 246 49.1 ± 0.7 48.3 ± 0.8 HB MALDI-TOF 160 80 1 171 73 2 7 3.78 0.05
Feng DW [7] 2016

Xinjiang,

China

365 370 46.8 ± 15.9 45.2 ± 16.4 PB PCR 317 48 0 304 63 3 9 0.02 0.89
Feng DW [7] 2016 Xinjiang,China 345 391 43.91 ± 14.27 41.51 ± 13.28 PB PCR 299 44 1 330 57 3 9 0.1 0.76
Zhu H [23] 2001

Sichuan,

China

134 255 54.7 ± 12.6 51.7 ± 10.9 PB PCR 123 11 0 238 17 0 7 0.3 0.58
Jia LQ [24] 2005

Sichuan,

China

118 109 58.1 ± 8.9 54.5 ± 9.6 NR PCR 105 13 0 99 10 0 6 0.25 0.62
Bora K [2] 2017 Assam, India 100 100 43.12 ± 11.64 42.95 ± 11.60 PB PCR-RFLP 89 11 0 87 13 0 8 0.48 0.49

SNP single nucleotide polymorphism, PB population-based; HB: hospital-based, HWE Hardy-Weinberg equilibrium, NR not reported